(Q34629600)

3 August 2017

title

Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation (English)

1 reference

3 August 2017

1 reference

Alan M Peaceman

5

0 references

Steve N Caritis

Steve N Caritis

1

0 references

Michael W. Varner

Michael W Varner

8

0 references

Yoram Sorokin

13

Yoram Sorokin

1 reference

3 August 2017

7

Catherine Y Spong

1 reference

3 August 2017

4

Dwight J Rouse

1 reference

Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

3 August 2017

18

Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

1 reference

3 August 2017

16

Susan Ramin

1 reference

3 August 2017

11

Brian M Mercer

1 reference

3 August 2017

10

Jay D Iams

1 reference

3 August 2017

9

Fergal D Malone

1 reference

3 August 2017

Margaret Hilda Harper

17

Margaret Harper

1 reference

3 August 2017

6

Anthony Sciscione

1 reference

3 August 2017

3

Raman Venkataramanan

1 reference

3 August 2017

2

Shringi Sharma

1 reference

3 August 2017

John M Thorp

12

1 reference

3 August 2017

Marshall Carpenter

14

1 reference

3 August 2017

Julie Lo

15

1 reference

3 August 2017

language of work or name

English

0 references

publication date

22 March 2011

1 reference

American Journal of Obstetrics and Gynecology

3 August 2017

published in

1 reference

3 August 2017

volume

205

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

40.e1-8

1 reference

17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Intramuscular 17α-hydroxyprogesterone caproate administration attenuates immunoresponsiveness of maternal peripheral blood mononuclear cells.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Effect of 17-alpha hydroxyprogesterone caproate on the production of tumor necrosis factor-alpha and the expression of cyclooxygenase-2 in lipopolysaccharide-treated gravid human myometrial explants.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Progestational agents prevent preterm birth induced by a nitric oxide synthesis inhibitor in the mouse

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

Identification of enzymes involved in the metabolism of 17alpha-hydroxyprogesterone caproate: an effective agent for prevention of preterm birth

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165062

A brief introduction to Monte Carlo simulation

26 October 2018

1 reference

12 December 2020

Intramuscular Administration of Hydroxyprogesterone Caproate in patients with Endometrial Carcinoma: Pharmacokinetics and effects on adrenal function

1 reference

12 December 2020

Pharmacokinetics of ritodrine administered intravenously: recommendations for changes in the current regimen

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of ritodrine after intramuscular administration to pregnant women

1 reference

12 December 2020

A Trial of 17 Alpha-Hydroxyprogesterone Caproate to Prevent Prematurity in Twins

1 reference

12 December 2020

10.1016/J.AJOG.2011.03.028

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference